Imipenem: all 30 studies that test it
Page 1 of 1. Open to participants first (4), then studies with results posted, then the rest; newest registration first within each.
- Targeted Versus Standard Peri-operative Antibiotic Prophylaxis in Patients Colonized With Carbapenemase Producing Enterobacterales Undergoing Liver TransplantationNot yet recruitingNCT07759453Phase 3
- Testing a Novel Combination Treatment (Arm D) Versus Standard of Care for Intensive Phase Treatment for Mycobacterium Abscessus Pulmonary Disease in People With or Without Cystic Fibrosis in the Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMaT) Adaptive Platform TrialNot yet recruitingNCT07485010Phase 2
- Bacteriophage Therapy for Mycobacterium Abscessus Pulmonary InfectionEnrolling by invitationNCT07228702Phase 1
- Finding the Optimal Regimen for Mycobacterium Abscessus TreatmentRecruitingNCT04310930Phase 2/3
- PHASE II SINGLE-CENTER, RANDOMIZED, OPEN-LABEL, PROSPECTIVE, STUDY TO DETERMINE THE IMPACT OF SERIAL PROCALCITONINCompletedNCT04983901Phase 2Results posted
- Safety, Tolerability, Efficacy and Pharmacokinetics of Imipenem/Cilastatin/Relebactam (MK-7655A) in Pediatric Participants With Gram-negative Bacterial Infection (MK-7655A-021)CompletedNCT03969901Phase 2/3Results posted
- Imipenem/Cilastatin/Relebactam (MK-7655A) Versus Piperacillin/Tazobactam in Participants With Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia (MK-7655A-016)CompletedNCT03583333Phase 3Results posted
- Efficacy and Safety of Imipenem+Cilastatin/Relebactam (MK-7655A) in Japanese Participants With Complicated Intra-abdominal Infection or Complicated Urinary Tract Infection (MK-7655A-017)CompletedNCT03293485Phase 3Results posted
- A Pharmacokinetics Study of MK-7655A in Pediatric Participants With Gram-negative Infections (MK-7655A-020)CompletedNCT03230916Phase 1Results posted
- Imipenem/Relebactam/Cilastatin Versus Piperacillin/Tazobactam for Treatment of Participants With Bacterial Pneumonia (MK-7655A-014)CompletedNCT02493764Phase 3Results posted
- Efficacy and Safety of Imipenem+Cilastatin/Relebactam (MK-7655A) Versus Colistimethate Sodium+Imipenem+Cilastatin in Imipenem-Resistant Bacterial Infection (MK-7655A-013)CompletedNCT02452047Phase 3Results posted
- Antibiotic Prophylaxis for Transrectal Prostate BiopsyCompletedNCT01659866Phase 4Results posted
- Imipenem/Cilastatin/Relebactam Pharmacokinetics, Safety, and Outcomes in Adults and Adolescents With Cystic FibrosisTerminatedNCT05561764Phase 4
- Impact of Obesity on the Pharmacokinetics of Imipenem-Relebactam in ICU PatientsWithdrawnNCT05146154Phase 4
- Imipenem/Cilastatin/Relebactam (IMI/REL) in Treatment of CRE InfectionsWithdrawnNCT04785924Phase 4
- Imipenem in Critically Ill PatientsStatus unknownNCT03776305Phase 4
- Antibacterial Prophylaxis vs no Prophylaxis for Hematological Malignancies Patients Before Allo-HSCTStatus unknownNCT03733340Phase 2/3
- Evaluation of Innovative Tools in Development of AntibioticsCompletedNCT03177720Phase 1
- Antimicrobial Treatment in Patients With Ventilator-associated TracheobronchitisTerminatedNCT03012360Phase 4
- Imipenem Prophylaxis in Patients With Acute PancreatitisCompletedNCT02897206Phase 4
- Effect of Aerosolised Colistin in Ventilator Associated PneumoniaCompletedNCT02683603Phase 4
- Preliminary Research On Two-step Dosing Of Imipenem/CilastatinStatus unknownNCT02616354Phase 4
- Comparison of the Pharmacodynamics of Imipenem in Patients With Febrile NeutropeniaCompletedNCT02213783Phase 4
- Imipenem Versus Cefepime in Spontaneous Bacterial Peritonitis and to Evaluate the Risk Factors for Treatment FailureCompletedNCT01852630Not applicable
- Empirical vs 2nd Line Antibiotic Therapy in Health-care Associated Infections in CirrhosisStatus unknownNCT01820026Phase 4
- The Population Pharmacokinetics of Imipenem in Patients With Ventilator-associated PneumoniaCompletedNCT01489124Phase 4
- Pharmacodynamics Study of Imipenem in Patients With Ventilator Associated PneumoniaCompletedNCT01379157Phase 4
- Impact of Imipenem With Amikacin Pharmacokinetic and PharmacodynamicCompletedNCT00950222Not applicable
- Fosfomycin Plus Imipenem for Treatment of Infective EndocarditisCompletedNCT00871104Phase 4
- Study Evaluating Tigecycline Versus Imipenem/Cilastatin in Hospital-Acquired PneumoniaCompletedNCT00080496Phase 3